カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の注射用トラスツズマブエムタンシン市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Trastuzumab Emtansine for Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19673）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19673
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：101
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の注射用トラスツズマブエムタンシン市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

注射用トラスツズマブエムタンシン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の注射用トラスツズマブエムタンシンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

注射用トラスツズマブエムタンシン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・60mg、100mg、150mg、160mg、その他

用途別セグメントは次のように区分されます。
・病院、診療所、その他

世界の注射用トラスツズマブエムタンシン市場の主要な市場プレーヤーは以下のとおりです。
・Genentech、Daiichi Sankyo、Amgen、Pfizer、Samsung Bioepis、Mylan(Viatris)、Celltrion、Roche、Accord Healthcare、Nippon Kayaku、Chugai Pharmaceutical、Henlius、Orifarm

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、注射用トラスツズマブエムタンシン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な注射用トラスツズマブエムタンシンメーカーの企業概要、2019年～2022年までの注射用トラスツズマブエムタンシンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な注射用トラスツズマブエムタンシンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別注射用トラスツズマブエムタンシンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの注射用トラスツズマブエムタンシンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での注射用トラスツズマブエムタンシン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および注射用トラスツズマブエムタンシンの産業チェーンを掲載しています。
・第13、14、15章では、注射用トラスツズマブエムタンシンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 注射用トラスツズマブエムタンシンの概要
- 種類別分析（2017年vs2021年vs2028年）：60mg、100mg、150mg、160mg、その他
- 用途別分析（2017年vs2021年vs2028年）：病院、診療所、その他
- 世界の注射用トラスツズマブエムタンシン市場規模・予測
- 世界の注射用トラスツズマブエムタンシン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Genentech、Daiichi Sankyo、Amgen、Pfizer、Samsung Bioepis、Mylan(Viatris)、Celltrion、Roche、Accord Healthcare、Nippon Kayaku、Chugai Pharmaceutical、Henlius、Orifarm
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：60mg、100mg、150mg、160mg、その他
・用途別分析2017年-2028年：病院、診療所、その他
・注射用トラスツズマブエムタンシンの北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・注射用トラスツズマブエムタンシンのヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・注射用トラスツズマブエムタンシンのアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・注射用トラスツズマブエムタンシンの南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・注射用トラスツズマブエムタンシンの中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Trastuzumab Emtansine for Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Trastuzumab Emtansine for Injection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospitals accounting for % of the Trastuzumab Emtansine for Injection global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While 60mg segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Trastuzumab Emtansine for Injection include Genentech, Daiichi Sankyo, Amgen, Pfizer, and Samsung Bioepis, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Trastuzumab Emtansine for Injection market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
60mg
100mg
150mg
160mg
Others
Market segment by Application can be divided into
Hospitals
Clinics
Others
The key market players for global Trastuzumab Emtansine for Injection market are listed below:
Genentech
Daiichi Sankyo
Amgen
Pfizer
Samsung Bioepis
Mylan(Viatris)
Celltrion
Roche
Accord Healthcare
Nippon Kayaku
Chugai Pharmaceutical
Henlius
Orifarm
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Trastuzumab Emtansine for Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Trastuzumab Emtansine for Injection, with price, sales, revenue and global market share of Trastuzumab Emtansine for Injection from 2019 to 2022.
Chapter 3, the Trastuzumab Emtansine for Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Trastuzumab Emtansine for Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Trastuzumab Emtansine for Injection market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Trastuzumab Emtansine for Injection.
Chapter 13, 14, and 15, to describe Trastuzumab Emtansine for Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Trastuzumab Emtansine for Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Trastuzumab Emtansine for Injection Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 60mg
1.2.3 100mg
1.2.4 150mg
1.2.5 160mg
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Trastuzumab Emtansine for Injection Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Trastuzumab Emtansine for Injection Market Size & Forecast
1.4.1 Global Trastuzumab Emtansine for Injection Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Trastuzumab Emtansine for Injection Sales in Volume (2017-2028)
1.4.3 Global Trastuzumab Emtansine for Injection Price (2017-2028)
1.5 Global Trastuzumab Emtansine for Injection Production Capacity Analysis
1.5.1 Global Trastuzumab Emtansine for Injection Total Production Capacity (2017-2028)
1.5.2 Global Trastuzumab Emtansine for Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Trastuzumab Emtansine for Injection Market Drivers
1.6.2 Trastuzumab Emtansine for Injection Market Restraints
1.6.3 Trastuzumab Emtansine for Injection Trends Analysis
2 Manufacturers Profiles
2.1 Genentech
2.1.1 Genentech Details
2.1.2 Genentech Major Business
2.1.3 Genentech Trastuzumab Emtansine for Injection Product and Services
2.1.4 Genentech Trastuzumab Emtansine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Daiichi Sankyo
2.2.1 Daiichi Sankyo Details
2.2.2 Daiichi Sankyo Major Business
2.2.3 Daiichi Sankyo Trastuzumab Emtansine for Injection Product and Services
2.2.4 Daiichi Sankyo Trastuzumab Emtansine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Amgen
2.3.1 Amgen Details
2.3.2 Amgen Major Business
2.3.3 Amgen Trastuzumab Emtansine for Injection Product and Services
2.3.4 Amgen Trastuzumab Emtansine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Trastuzumab Emtansine for Injection Product and Services
2.4.4 Pfizer Trastuzumab Emtansine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Samsung Bioepis
2.5.1 Samsung Bioepis Details
2.5.2 Samsung Bioepis Major Business
2.5.3 Samsung Bioepis Trastuzumab Emtansine for Injection Product and Services
2.5.4 Samsung Bioepis Trastuzumab Emtansine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Mylan(Viatris)
2.6.1 Mylan(Viatris) Details
2.6.2 Mylan(Viatris) Major Business
2.6.3 Mylan(Viatris) Trastuzumab Emtansine for Injection Product and Services
2.6.4 Mylan(Viatris) Trastuzumab Emtansine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Celltrion
2.7.1 Celltrion Details
2.7.2 Celltrion Major Business
2.7.3 Celltrion Trastuzumab Emtansine for Injection Product and Services
2.7.4 Celltrion Trastuzumab Emtansine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business
2.8.3 Roche Trastuzumab Emtansine for Injection Product and Services
2.8.4 Roche Trastuzumab Emtansine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Accord Healthcare
2.9.1 Accord Healthcare Details
2.9.2 Accord Healthcare Major Business
2.9.3 Accord Healthcare Trastuzumab Emtansine for Injection Product and Services
2.9.4 Accord Healthcare Trastuzumab Emtansine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Nippon Kayaku
2.10.1 Nippon Kayaku Details
2.10.2 Nippon Kayaku Major Business
2.10.3 Nippon Kayaku Trastuzumab Emtansine for Injection Product and Services
2.10.4 Nippon Kayaku Trastuzumab Emtansine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Chugai Pharmaceutical
2.11.1 Chugai Pharmaceutical Details
2.11.2 Chugai Pharmaceutical Major Business
2.11.3 Chugai Pharmaceutical Trastuzumab Emtansine for Injection Product and Services
2.11.4 Chugai Pharmaceutical Trastuzumab Emtansine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Henlius
2.12.1 Henlius Details
2.12.2 Henlius Major Business
2.12.3 Henlius Trastuzumab Emtansine for Injection Product and Services
2.12.4 Henlius Trastuzumab Emtansine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Orifarm
2.13.1 Orifarm Details
2.13.2 Orifarm Major Business
2.13.3 Orifarm Trastuzumab Emtansine for Injection Product and Services
2.13.4 Orifarm Trastuzumab Emtansine for Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Trastuzumab Emtansine for Injection Breakdown Data by Manufacturer
3.1 Global Trastuzumab Emtansine for Injection Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Trastuzumab Emtansine for Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Trastuzumab Emtansine for Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Trastuzumab Emtansine for Injection Manufacturer Market Share in 2021
3.4.2 Top 6 Trastuzumab Emtansine for Injection Manufacturer Market Share in 2021
3.5 Global Trastuzumab Emtansine for Injection Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Trastuzumab Emtansine for Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Trastuzumab Emtansine for Injection Market Size by Region
4.1.1 Global Trastuzumab Emtansine for Injection Sales in Volume by Region (2017-2028)
4.1.2 Global Trastuzumab Emtansine for Injection Revenue by Region (2017-2028)
4.2 North America Trastuzumab Emtansine for Injection Revenue (2017-2028)
4.3 Europe Trastuzumab Emtansine for Injection Revenue (2017-2028)
4.4 Asia-Pacific Trastuzumab Emtansine for Injection Revenue (2017-2028)
4.5 South America Trastuzumab Emtansine for Injection Revenue (2017-2028)
4.6 Middle East and Africa Trastuzumab Emtansine for Injection Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Trastuzumab Emtansine for Injection Sales in Volume by Type (2017-2028)
5.2 Global Trastuzumab Emtansine for Injection Revenue by Type (2017-2028)
5.3 Global Trastuzumab Emtansine for Injection Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Trastuzumab Emtansine for Injection Sales in Volume by Application (2017-2028)
6.2 Global Trastuzumab Emtansine for Injection Revenue by Application (2017-2028)
6.3 Global Trastuzumab Emtansine for Injection Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Trastuzumab Emtansine for Injection Sales by Type (2017-2028)
7.2 North America Trastuzumab Emtansine for Injection Sales by Application (2017-2028)
7.3 North America Trastuzumab Emtansine for Injection Market Size by Country
7.3.1 North America Trastuzumab Emtansine for Injection Sales in Volume by Country (2017-2028)
7.3.2 North America Trastuzumab Emtansine for Injection Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Trastuzumab Emtansine for Injection Sales by Type (2017-2028)
8.2 Europe Trastuzumab Emtansine for Injection Sales by Application (2017-2028)
8.3 Europe Trastuzumab Emtansine for Injection Market Size by Country
8.3.1 Europe Trastuzumab Emtansine for Injection Sales in Volume by Country (2017-2028)
8.3.2 Europe Trastuzumab Emtansine for Injection Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Trastuzumab Emtansine for Injection Sales by Type (2017-2028)
9.2 Asia-Pacific Trastuzumab Emtansine for Injection Sales by Application (2017-2028)
9.3 Asia-Pacific Trastuzumab Emtansine for Injection Market Size by Region
9.3.1 Asia-Pacific Trastuzumab Emtansine for Injection Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Trastuzumab Emtansine for Injection Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Trastuzumab Emtansine for Injection Sales by Type (2017-2028)
10.2 South America Trastuzumab Emtansine for Injection Sales by Application (2017-2028)
10.3 South America Trastuzumab Emtansine for Injection Market Size by Country
10.3.1 South America Trastuzumab Emtansine for Injection Sales in Volume by Country (2017-2028)
10.3.2 South America Trastuzumab Emtansine for Injection Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Trastuzumab Emtansine for Injection Sales by Type (2017-2028)
11.2 Middle East & Africa Trastuzumab Emtansine for Injection Sales by Application (2017-2028)
11.3 Middle East & Africa Trastuzumab Emtansine for Injection Market Size by Country
11.3.1 Middle East & Africa Trastuzumab Emtansine for Injection Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Trastuzumab Emtansine for Injection Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Trastuzumab Emtansine for Injection and Key Manufacturers
12.2 Manufacturing Costs Percentage of Trastuzumab Emtansine for Injection
12.3 Trastuzumab Emtansine for Injection Production Process
12.4 Trastuzumab Emtansine for Injection Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Trastuzumab Emtansine for Injection Typical Distributors
13.3 Trastuzumab Emtansine for Injection Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Trastuzumab Emtansine for Injection Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Trastuzumab Emtansine for Injection Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Genentech Basic Information, Manufacturing Base and Competitors
Table 4. Genentech Major Business
Table 5. Genentech Trastuzumab Emtansine for Injection Product and Services
Table 6. Genentech Trastuzumab Emtansine for Injection Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Daiichi Sankyo Basic Information, Manufacturing Base and Competitors
Table 8. Daiichi Sankyo Major Business
Table 9. Daiichi Sankyo Trastuzumab Emtansine for Injection Product and Services
Table 10. Daiichi Sankyo Trastuzumab Emtansine for Injection Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Amgen Basic Information, Manufacturing Base and Competitors
Table 12. Amgen Major Business
Table 13. Amgen Trastuzumab Emtansine for Injection Product and Services
Table 14. Amgen Trastuzumab Emtansine for Injection Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Pfizer Basic Information, Manufacturing Base and Competitors
Table 16. Pfizer Major Business
Table 17. Pfizer Trastuzumab Emtansine for Injection Product and Services
Table 18. Pfizer Trastuzumab Emtansine for Injection Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 20. Samsung Bioepis Major Business
Table 21. Samsung Bioepis Trastuzumab Emtansine for Injection Product and Services
Table 22. Samsung Bioepis Trastuzumab Emtansine for Injection Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Mylan(Viatris) Basic Information, Manufacturing Base and Competitors
Table 24. Mylan(Viatris) Major Business
Table 25. Mylan(Viatris) Trastuzumab Emtansine for Injection Product and Services
Table 26. Mylan(Viatris) Trastuzumab Emtansine for Injection Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Celltrion Basic Information, Manufacturing Base and Competitors
Table 28. Celltrion Major Business
Table 29. Celltrion Trastuzumab Emtansine for Injection Product and Services
Table 30. Celltrion Trastuzumab Emtansine for Injection Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Roche Basic Information, Manufacturing Base and Competitors
Table 32. Roche Major Business
Table 33. Roche Trastuzumab Emtansine for Injection Product and Services
Table 34. Roche Trastuzumab Emtansine for Injection Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Accord Healthcare Basic Information, Manufacturing Base and Competitors
Table 36. Accord Healthcare Major Business
Table 37. Accord Healthcare Trastuzumab Emtansine for Injection Product and Services
Table 38. Accord Healthcare Trastuzumab Emtansine for Injection Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Nippon Kayaku Basic Information, Manufacturing Base and Competitors
Table 40. Nippon Kayaku Major Business
Table 41. Nippon Kayaku Trastuzumab Emtansine for Injection Product and Services
Table 42. Nippon Kayaku Trastuzumab Emtansine for Injection Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Chugai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Chugai Pharmaceutical Major Business
Table 45. Chugai Pharmaceutical Trastuzumab Emtansine for Injection Product and Services
Table 46. Chugai Pharmaceutical Trastuzumab Emtansine for Injection Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Henlius Basic Information, Manufacturing Base and Competitors
Table 48. Henlius Major Business
Table 49. Henlius Trastuzumab Emtansine for Injection Product and Services
Table 50. Henlius Trastuzumab Emtansine for Injection Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Orifarm Basic Information, Manufacturing Base and Competitors
Table 52. Orifarm Major Business
Table 53. Orifarm Trastuzumab Emtansine for Injection Product and Services
Table 54. Orifarm Trastuzumab Emtansine for Injection Sales (K L), Price (US$/L), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Trastuzumab Emtansine for Injection Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K L)
Table 56. Global Trastuzumab Emtansine for Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Trastuzumab Emtansine for Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Trastuzumab Emtansine for Injection Production Capacity by Company, (K L): 2020 VS 2021
Table 59. Head Office and Trastuzumab Emtansine for Injection Production Site of Key Manufacturer
Table 60. Trastuzumab Emtansine for Injection New Entrant and Capacity Expansion Plans
Table 61. Trastuzumab Emtansine for Injection Mergers & Acquisitions in the Past Five Years
Table 62. Global Trastuzumab Emtansine for Injection Sales by Region (2017-2022) & (K L)
Table 63. Global Trastuzumab Emtansine for Injection Sales by Region (2023-2028) & (K L)
Table 64. Global Trastuzumab Emtansine for Injection Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Trastuzumab Emtansine for Injection Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Trastuzumab Emtansine for Injection Sales by Type (2017-2022) & (K L)
Table 67. Global Trastuzumab Emtansine for Injection Sales by Type (2023-2028) & (K L)
Table 68. Global Trastuzumab Emtansine for Injection Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Trastuzumab Emtansine for Injection Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Trastuzumab Emtansine for Injection Price by Type (2017-2022) & (US$/L)
Table 71. Global Trastuzumab Emtansine for Injection Price by Type (2023-2028) & (US$/L)
Table 72. Global Trastuzumab Emtansine for Injection Sales by Application (2017-2022) & (K L)
Table 73. Global Trastuzumab Emtansine for Injection Sales by Application (2023-2028) & (K L)
Table 74. Global Trastuzumab Emtansine for Injection Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Trastuzumab Emtansine for Injection Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Trastuzumab Emtansine for Injection Price by Application (2017-2022) & (US$/L)
Table 77. Global Trastuzumab Emtansine for Injection Price by Application (2023-2028) & (US$/L)
Table 78. North America Trastuzumab Emtansine for Injection Sales by Country (2017-2022) & (K L)
Table 79. North America Trastuzumab Emtansine for Injection Sales by Country (2023-2028) & (K L)
Table 80. North America Trastuzumab Emtansine for Injection Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Trastuzumab Emtansine for Injection Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Trastuzumab Emtansine for Injection Sales by Type (2017-2022) & (K L)
Table 83. North America Trastuzumab Emtansine for Injection Sales by Type (2023-2028) & (K L)
Table 84. North America Trastuzumab Emtansine for Injection Sales by Application (2017-2022) & (K L)
Table 85. North America Trastuzumab Emtansine for Injection Sales by Application (2023-2028) & (K L)
Table 86. Europe Trastuzumab Emtansine for Injection Sales by Country (2017-2022) & (K L)
Table 87. Europe Trastuzumab Emtansine for Injection Sales by Country (2023-2028) & (K L)
Table 88. Europe Trastuzumab Emtansine for Injection Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Trastuzumab Emtansine for Injection Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Trastuzumab Emtansine for Injection Sales by Type (2017-2022) & (K L)
Table 91. Europe Trastuzumab Emtansine for Injection Sales by Type (2023-2028) & (K L)
Table 92. Europe Trastuzumab Emtansine for Injection Sales by Application (2017-2022) & (K L)
Table 93. Europe Trastuzumab Emtansine for Injection Sales by Application (2023-2028) & (K L)
Table 94. Asia-Pacific Trastuzumab Emtansine for Injection Sales by Region (2017-2022) & (K L)
Table 95. Asia-Pacific Trastuzumab Emtansine for Injection Sales by Region (2023-2028) & (K L)
Table 96. Asia-Pacific Trastuzumab Emtansine for Injection Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Trastuzumab Emtansine for Injection Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Trastuzumab Emtansine for Injection Sales by Type (2017-2022) & (K L)
Table 99. Asia-Pacific Trastuzumab Emtansine for Injection Sales by Type (2023-2028) & (K L)
Table 100. Asia-Pacific Trastuzumab Emtansine for Injection Sales by Application (2017-2022) & (K L)
Table 101. Asia-Pacific Trastuzumab Emtansine for Injection Sales by Application (2023-2028) & (K L)
Table 102. South America Trastuzumab Emtansine for Injection Sales by Country (2017-2022) & (K L)
Table 103. South America Trastuzumab Emtansine for Injection Sales by Country (2023-2028) & (K L)
Table 104. South America Trastuzumab Emtansine for Injection Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Trastuzumab Emtansine for Injection Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Trastuzumab Emtansine for Injection Sales by Type (2017-2022) & (K L)
Table 107. South America Trastuzumab Emtansine for Injection Sales by Type (2023-2028) & (K L)
Table 108. South America Trastuzumab Emtansine for Injection Sales by Application (2017-2022) & (K L)
Table 109. South America Trastuzumab Emtansine for Injection Sales by Application (2023-2028) & (K L)
Table 110. Middle East & Africa Trastuzumab Emtansine for Injection Sales by Region (2017-2022) & (K L)
Table 111. Middle East & Africa Trastuzumab Emtansine for Injection Sales by Region (2023-2028) & (K L)
Table 112. Middle East & Africa Trastuzumab Emtansine for Injection Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Trastuzumab Emtansine for Injection Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Trastuzumab Emtansine for Injection Sales by Type (2017-2022) & (K L)
Table 115. Middle East & Africa Trastuzumab Emtansine for Injection Sales by Type (2023-2028) & (K L)
Table 116. Middle East & Africa Trastuzumab Emtansine for Injection Sales by Application (2017-2022) & (K L)
Table 117. Middle East & Africa Trastuzumab Emtansine for Injection Sales by Application (2023-2028) & (K L)
Table 118. Trastuzumab Emtansine for Injection Raw Material
Table 119. Key Manufacturers of Trastuzumab Emtansine for Injection Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Trastuzumab Emtansine for Injection Typical Distributors
Table 123. Trastuzumab Emtansine for Injection Typical Customers
List of Figures
Figure 1. Trastuzumab Emtansine for Injection Picture
Figure 2. Global Trastuzumab Emtansine for Injection Revenue Market Share by Type in 2021
Figure 3. 60mg
Figure 4. 100mg
Figure 5. 150mg
Figure 6. 160mg
Figure 7. Others
Figure 8. Global Trastuzumab Emtansine for Injection Revenue Market Share by Application in 2021
Figure 9. Hospitals
Figure 10. Clinics
Figure 11. Others
Figure 12. Global Trastuzumab Emtansine for Injection Revenue, (USD Million) & (K L): 2017 & 2021 & 2028
Figure 13. Global Trastuzumab Emtansine for Injection Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Trastuzumab Emtansine for Injection Sales (2017-2028) & (K L)
Figure 15. Global Trastuzumab Emtansine for Injection Price (2017-2028) & (US$/L)
Figure 16. Global Trastuzumab Emtansine for Injection Production Capacity (2017-2028) & (K L)
Figure 17. Global Trastuzumab Emtansine for Injection Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Trastuzumab Emtansine for Injection Market Drivers
Figure 19. Trastuzumab Emtansine for Injection Market Restraints
Figure 20. Trastuzumab Emtansine for Injection Market Trends
Figure 21. Global Trastuzumab Emtansine for Injection Sales Market Share by Manufacturer in 2021
Figure 22. Global Trastuzumab Emtansine for Injection Revenue Market Share by Manufacturer in 2021
Figure 23. Trastuzumab Emtansine for Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Trastuzumab Emtansine for Injection Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Trastuzumab Emtansine for Injection Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Trastuzumab Emtansine for Injection Sales Market Share by Region (2017-2028)
Figure 27. Global Trastuzumab Emtansine for Injection Revenue Market Share by Region (2017-2028)
Figure 28. North America Trastuzumab Emtansine for Injection Revenue (2017-2028) & (USD Million)
Figure 29. Europe Trastuzumab Emtansine for Injection Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Trastuzumab Emtansine for Injection Revenue (2017-2028) & (USD Million)
Figure 31. South America Trastuzumab Emtansine for Injection Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Trastuzumab Emtansine for Injection Revenue (2017-2028) & (USD Million)
Figure 33. Global Trastuzumab Emtansine for Injection Sales Market Share by Type (2017-2028)
Figure 34. Global Trastuzumab Emtansine for Injection Revenue Market Share by Type (2017-2028)
Figure 35. Global Trastuzumab Emtansine for Injection Price by Type (2017-2028) & (US$/L)
Figure 36. Global Trastuzumab Emtansine for Injection Sales Market Share by Application (2017-2028)
Figure 37. Global Trastuzumab Emtansine for Injection Revenue Market Share by Application (2017-2028)
Figure 38. Global Trastuzumab Emtansine for Injection Price by Application (2017-2028) & (US$/L)
Figure 39. North America Trastuzumab Emtansine for Injection Sales Market Share by Type (2017-2028)
Figure 40. North America Trastuzumab Emtansine for Injection Sales Market Share by Application (2017-2028)
Figure 41. North America Trastuzumab Emtansine for Injection Sales Market Share by Country (2017-2028)
Figure 42. North America Trastuzumab Emtansine for Injection Revenue Market Share by Country (2017-2028)
Figure 43. United States Trastuzumab Emtansine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Trastuzumab Emtansine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Trastuzumab Emtansine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Trastuzumab Emtansine for Injection Sales Market Share by Type (2017-2028)
Figure 47. Europe Trastuzumab Emtansine for Injection Sales Market Share by Application (2017-2028)
Figure 48. Europe Trastuzumab Emtansine for Injection Sales Market Share by Country (2017-2028)
Figure 49. Europe Trastuzumab Emtansine for Injection Revenue Market Share by Country (2017-2028)
Figure 50. Germany Trastuzumab Emtansine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Trastuzumab Emtansine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Trastuzumab Emtansine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Trastuzumab Emtansine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Trastuzumab Emtansine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Trastuzumab Emtansine for Injection Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Trastuzumab Emtansine for Injection Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Trastuzumab Emtansine for Injection Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Trastuzumab Emtansine for Injection Revenue Market Share by Region (2017-2028)
Figure 59. China Trastuzumab Emtansine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Trastuzumab Emtansine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Trastuzumab Emtansine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Trastuzumab Emtansine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Trastuzumab Emtansine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Trastuzumab Emtansine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Trastuzumab Emtansine for Injection Sales Market Share by Type (2017-2028)
Figure 66. South America Trastuzumab Emtansine for Injection Sales Market Share by Application (2017-2028)
Figure 67. South America Trastuzumab Emtansine for Injection Sales Market Share by Country (2017-2028)
Figure 68. South America Trastuzumab Emtansine for Injection Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Trastuzumab Emtansine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Trastuzumab Emtansine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Trastuzumab Emtansine for Injection Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Trastuzumab Emtansine for Injection Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Trastuzumab Emtansine for Injection Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Trastuzumab Emtansine for Injection Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Trastuzumab Emtansine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Trastuzumab Emtansine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Trastuzumab Emtansine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Trastuzumab Emtansine for Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Trastuzumab Emtansine for Injection in 2021
Figure 80. Manufacturing Process Analysis of Trastuzumab Emtansine for Injection
Figure 81. Trastuzumab Emtansine for Injection Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界のリラグルチド注射市場2022年：市場規模予測（～2028年）
  • 世界のエダラボン注射市場2022年：市場規模予測（～2028年）
  • 世界のバシリキシマブ注射市場2022年：市場規模予測（～2028年）
  • 世界のクリスビタ注射市場2022年：市場規模予測（～2028年）
  • 世界のヴェノファー（鉄ショ糖注射液）市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19673 )"世界の注射用トラスツズマブエムタンシン市場2022年：市場規模予測（～2028年）" (英文：Global Trastuzumab Emtansine for Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。